Detalhe da pesquisa
1.
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Cancer
; 129(24): 3905-3914, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572086
2.
Amyloidogenic light chains impair plasma cell survival.
Haematologica
; 108(12): 3359-3371, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381778
3.
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Haematologica
; 108(7): 1827-1839, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200421
4.
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime.
Hematol Oncol
; 41(5): 838-847, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403752
5.
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma.
Eur J Haematol
; 110(4): 407-413, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565290
6.
Kinetics of response to first- and second-line therapies in multiple myeloma: Assessment by both M-spikes and light chains.
Eur J Haematol
; 108(3): 204-211, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767270
7.
Characteristics and outcomes of adults with cytomegalovirus-associated thrombocytopenia: a case series and literature review.
Br J Haematol
; 191(5): 863-867, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744725
8.
Belantamab mafodotin in the treatment of relapsed or refractory multiple myeloma.
Future Oncol
; 16(34): 2783-2798, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32875817
9.
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
Am J Hematol
; 94(9): 992-1001, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211434
10.
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma.
Acta Haematol
; 141(4): 216-221, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943470
11.
Do older patients truly benefit from advances in myeloma care?
Haematologica
; 108(6): 1470-1472, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300777
12.
Immune Therapies in AL Amyloidosis-A Glimpse to the Future.
Cancers (Basel)
; 16(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672686
13.
Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma.
Clin Lymphoma Myeloma Leuk
; 24(3): 187-193.e1, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008594
14.
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.
Blood Adv
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768428
15.
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
Transplant Cell Ther
; 29(8): 505.e1-505.e8, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160229
16.
The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 23(11): 850-856, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689547
17.
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study.
Cancers (Basel)
; 15(6)2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980596
18.
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
Cancers (Basel)
; 15(13)2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444582
19.
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
Leuk Lymphoma
; 63(5): 1144-1151, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963410
20.
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma.
J Clin Med
; 11(7)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35407416